Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
---|
11/01/2006 | CN1853718A Positioning composition for oral liquid and its preparation |
11/01/2006 | CN1853702A Chinese medicinal preparation for lowering blood sugar, blood fat and blood pressure, improving blood flow and immune and its making method |
11/01/2006 | CN1853668A Chinese medicinal composition for strengthening body and enriching blood |
11/01/2006 | CN1853657A Use of three chromium-enriched biological materials in medicine for treating allergic rhinitis |
11/01/2006 | CN1853656A Fermentation composition having immunomodulating effect |
11/01/2006 | CN1853506A Health-care food for improving human immunity and production thereof |
11/01/2006 | CN1282636C Vitamin D analogues |
11/01/2006 | CN1282471C Medicine for treating anaphylactic dermatosis |
11/01/2006 | CN1282452C Use of aminoadamantane compound as immunoregulators |
10/31/2006 | US7129366 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
10/31/2006 | US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
10/31/2006 | US7129270 Antiinflammatory agents |
10/31/2006 | US7129247 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
10/31/2006 | US7129244 Triazolopyrimidines and related analogs as HSP90-inhibitors |
10/31/2006 | US7129243 Respiratory system disorders; cardiovascular disorders; antidiabetic agents; antiarthritic agents; antiinflammatory agents; immunosuppressants |
10/31/2006 | US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions |
10/31/2006 | US7129241 Pyridazine derivatives |
10/31/2006 | US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
10/31/2006 | US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
10/31/2006 | US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
10/31/2006 | US7129222 Immunomodulatory formulations and methods for use thereof |
10/31/2006 | US7129219 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group |
10/31/2006 | US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated. |
10/31/2006 | CA2329217C Stable extended release oral dosage composition comprising desloratadine and pseudoephedrine |
10/31/2006 | CA2276455C Phthalazinones |
10/31/2006 | CA2262796C 4-substituted beta-carbolines as immunomodulators |
10/31/2006 | CA2174731C Rapamycin derivatives useful as immunosuppressants |
10/31/2006 | CA2142811C Novel glucan preparation |
10/26/2006 | WO2006113942A2 Method of inhibiting cathepsin activity |
10/26/2006 | WO2006113572A1 Methods of increasing natural killer cell activity for therapy |
10/26/2006 | WO2006113308A1 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
10/26/2006 | WO2006112331A1 Novel condensed pyrrole derivative |
10/26/2006 | WO2006111783A1 Monosaccharide derivatives as anti-inflammatory and/or anti-cancer agents |
10/26/2006 | WO2006111296A2 Dosage forms and combined preparations of pyrimidine biosynthesis inhibitors for achieving additional effects upon the immune system |
10/26/2006 | WO2006111060A1 A method for isolating and purifying immuno-modulating polypeptide from cow placenta |
10/26/2006 | WO2006091103A3 Nutritional composition with probiotics |
10/26/2006 | WO2006084210A9 Hif modulating compounds and methods of use thereof |
10/26/2006 | WO2002101008A3 Intracellular signaling molecules |
10/26/2006 | US20060242716 Disease model animal carrying foreign ppar alpha gene transferred thereinto and use thereof |
10/26/2006 | US20060241303 Piperidine derivatives and process for their production |
10/26/2006 | US20060241286 Novel peptides and the application thereof in therapy |
10/26/2006 | US20060241155 TNF-alpha production inhibitors |
10/26/2006 | US20060241132 Spiro derivatives and adhesion molecule inhibitors comprising the same as active ingredient |
10/26/2006 | US20060241131 Pyrrolo[2,3-d]pyrimidine compounds |
10/26/2006 | US20060241116 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
10/26/2006 | US20060241112 Kinase inhibitors |
10/26/2006 | US20060241087 Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity |
10/26/2006 | US20060240520 monitoring the efficacy of a BAFF-R (a B-cell activating factor belonging to the Tumor Necrosis Factor family) antagonist in the treatment of a disease or disorder associated with aberrant levels of B-cells or B-cell activity |
10/26/2006 | US20060240519 Novel receptor nucleic acids and polypeptides |
10/26/2006 | US20060240518 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells |
10/26/2006 | US20060240517 Novel receptor nucleic acids and polypeptides |
10/26/2006 | US20060240045 Neisserial vaccine compositions comprising a combination of antigens |
10/26/2006 | US20060240023 Apoptosis-associated protein and use thereof |
10/26/2006 | US20060240020 Inhibition of complement activation |
10/26/2006 | US20060240010 Methods of modulating CD200 receptors |
10/26/2006 | US20060240000 Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound |
10/26/2006 | US20060239991 polypeptide has the biological activity of methionyl tRNA synthetase; for the protection against bacterial infections |
10/26/2006 | US20060239990 Protein Arginine N-Methyltransferase 2 (PRMT-2) |
10/26/2006 | US20060239979 Dendritic cell presenting a-glycosylceramide derivative and antigent and usable in suppressing immune response |
10/26/2006 | US20060239936 Delivery of anti-migraine compounds through an inhalation route |
10/26/2006 | US20060237004 Methods for treating trigeminal neuralgia |
10/26/2006 | US20060237003 Methods for treating headaches |
10/26/2006 | DE20321278U1 Cosmetic or dermatological preparation in water-in-oil emulsion form, useful to treat e.g. neurodermatitis, dyskeratoses and scars, comprises phytosterols and optionally additional materials |
10/26/2006 | DE20321277U1 Cosmetic/dermatological preparation in form of oil-in water emulsion, useful for treating e.g. neurodermatitis and skin aging, comprises phytosterol groups, oil components and additional materials |
10/26/2006 | DE102005020105A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
10/26/2006 | DE102005020104A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
10/26/2006 | CA2605402A1 Antibody neutralizers of human granulocyte macrophage colony stimulating factor |
10/26/2006 | CA2605020A1 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody |
10/26/2006 | CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof |
10/26/2006 | CA2603314A1 Methods of increasing natural killer cell activity for therapy |
10/25/2006 | EP1715045A2 Recombinant antibodies for human therapy |
10/25/2006 | EP1715034A1 Regulatory cell controlling immunological activity of t cell |
10/25/2006 | EP1714981A2 Method for the identification of antigenic peptides |
10/25/2006 | EP1714980A1 Human receptor proteins, related reagents and methods |
10/25/2006 | EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
10/25/2006 | EP1714977A2 Synthesis of cyclosporin analogs |
10/25/2006 | EP1714976A1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
10/25/2006 | EP1714969A2 Immunostimulatory nucleic acid molecules |
10/25/2006 | EP1714635A1 Process for producing maca extract |
10/25/2006 | EP1713914A2 MEDICAL TREATMENT USING AN RNAi AGENT TARGETING A HUMAN NOTCH SIGNALLING PATHWAY MEMBER |
10/25/2006 | EP1713495A2 Method of inducing or modulating immune response |
10/25/2006 | EP1560830B1 Derivatives of [6, 7-dihydro-5h-imidazo[1,2 - a]imidazole -3 -sulfonylamino]-propionamide and their use as inhibitors upon the interaction of cams and leukointegrins |
10/25/2006 | EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
10/25/2006 | EP1495767B1 Immunoadjuvant |
10/25/2006 | EP1430053B1 AZAOXOINDOLE DERIVATIVES AS Trk PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF CANCER AND CHRONIC PAIN |
10/25/2006 | EP1377275B1 Vaccine for modulating between t1 and t2 immune responses |
10/25/2006 | EP1313476B1 Sgk3 used as diagnostic and therapeutic target |
10/25/2006 | EP1265606B1 Cell adhesion inhibitors |
10/25/2006 | EP1187613B9 Amide substituted imidazoquinolines |
10/25/2006 | EP0973802B1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses |
10/25/2006 | EP0827408B1 Method of administration of igf-i |
10/25/2006 | CN1852988A Quantitative method for detecting yessotoxins in fish products based on the activation caused by the toxin in cellular phosphodiesterase and therapeutic usefulness of said activation |
10/25/2006 | CN1852923A Human antibody molecules for IL-13 |
10/25/2006 | CN1852730A Modulators of P-selectin glycoprotein ligand 1 |
10/25/2006 | CN1852709A Macrophage activation inhibitor |
10/25/2006 | CN1852708A Human beta-defensin secretion promoter |
10/25/2006 | CN1850857A Rana grahami propyl sperm peptide, gene and variant and its pharmaceutical use |
10/25/2006 | CN1850153A Method for preparing Radix puerariae and cenlian decoction |
10/25/2006 | CN1850149A Compounded preparation of Radix As tragali seu Hedy ari extract and mushroom polysaccharide and preparing method |